AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 139.73 million. The enterprise value is 107.28 million.
Market Cap | 139.73M |
Enterprise Value | 107.28M |
Important Dates
The last earnings date was Tuesday, August 19, 2025.
Earnings Date | Aug 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 234.44 million shares outstanding. The number of shares has increased by 180.61% in one year.
Current Share Class | 234.44M |
Shares Outstanding | 234.44M |
Shares Change (YoY) | +180.61% |
Shares Change (QoQ) | +16.05% |
Owned by Insiders (%) | 0.32% |
Owned by Institutions (%) | 18.17% |
Float | 233.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 17.48 |
PB Ratio | 2.00 |
P/TBV Ratio | 2.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.46 |
EV / Sales | 13.42 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.79
Current Ratio | 7.79 |
Quick Ratio | 7.60 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -219.32 |
Financial Efficiency
Return on equity (ROE) is -39.80% and return on invested capital (ROIC) is -25.15%.
Return on Equity (ROE) | -39.80% |
Return on Assets (ROA) | -23.73% |
Return on Invested Capital (ROIC) | -25.15% |
Return on Capital Employed (ROCE) | -34.80% |
Revenue Per Employee | 2.00M |
Profits Per Employee | -6.02M |
Employee Count | 4 |
Asset Turnover | 0.12 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.04% in the last 52 weeks. The beta is 1.19, so AcuCort AB's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | -44.04% |
50-Day Moving Average | 0.67 |
200-Day Moving Average | 0.75 |
Relative Strength Index (RSI) | 43.60 |
Average Volume (20 Days) | 402,435 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 8.00 million and -24.08 million in losses. Loss per share was -0.15.
Revenue | 8.00M |
Gross Profit | -10.99M |
Operating Income | -24.34M |
Pretax Income | -24.08M |
Net Income | -24.08M |
EBITDA | n/a |
EBIT | -24.34M |
Loss Per Share | -0.15 |
Balance Sheet
The company has 32.44 million in cash and n/a in debt, giving a net cash position of 32.44 million or 0.14 per share.
Cash & Cash Equivalents | 32.44M |
Total Debt | n/a |
Net Cash | 32.44M |
Net Cash Per Share | 0.14 |
Equity (Book Value) | 69.96M |
Book Value Per Share | 0.30 |
Working Capital | 30.02M |
Cash Flow
Operating Cash Flow | -15.16M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | -137.40% |
Operating Margin | -304.49% |
Pretax Margin | -301.13% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -180.61% |
Shareholder Yield | n/a |
Earnings Yield | -17.23% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 15.31 and a Piotroski F-Score of 2.
Altman Z-Score | 15.31 |
Piotroski F-Score | 2 |